THE GENETIC-ANALYSIS OF OVARIAN-CANCER

[1] LOSS OF HETEROZYGOSITY ON CHROMOSOME-5 IN SPORADIC OVARIAN-CARCINOMA IS A LATE EVENT AND IS NOT ASSOCIATED WITH MUTATIONS IN APC AT 5Q21-22 [J]. HUMAN MUTATION, 1994, 3 (03) : 283 - 291

[2] ALLELOTYPE STUDY OF ESOPHAGEAL-CARCINOMA [J]. GENES CHROMOSOMES & CANCER, 1994, 10 (03) : 177 - 182

[3] ABNORMAL CHROMOSOMES INCLUDING SMALL METACENTRICS IN 14 OVARIAN CANCERS [J]. CANCER GENETICS AND CYTOGENETICS, 1987, 26 (02) : 355 - 361

[4] CHROMOSOME-ABERRATIONS IN METASTATIC OVARIAN-CANCER - RELATIONSHIP WITH ABNORMALITIES IN PRIMARY TUMORS [J]. INTERNATIONAL JOURNAL OF CANCER, 1990, 45 (01) : 50 - 54

[5] BERCHUCK A, 1992, HEMATOL ONCOL CLIN N, V6, P813

[6] OVEREXPRESSION OF P53 IS NOT A FEATURE OF BENIGN AND EARLY-STAGE BORDERLINE EPITHELIAL OVARIAN-TUMORS [J]. GYNECOLOGIC ONCOLOGY, 1994, 52 (02) : 232 - 236

[7] BEREK JS, 1993, ANN ONCOL, V4, P3

[8] THE SEARCH FOR THE FAMILIAL BREAST OVARIAN-CANCER GENE [J]. TRENDS IN GENETICS, 1993, 9 (01) : 22 - 26

[9] CONCLUSIONS AND RECOMMENDATIONS FROM THE HELENE-HARRIS-MEMORIAL-TRUST 4TH BIENNIAL INTERNATIONAL FORUM ON OVARIAN-CANCER 11-14 MAY 1993, TORONTO, CANADA [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1994, 4 (02) : 135 - 143

[10] DEMONSTRATION OF SOMATIC REARRANGEMENTS AND GENOMIC HETEROGENEITY IN HUMAN OVARIAN-CANCER BY DNA FINGERPRINTING [J]. BRITISH JOURNAL OF CANCER, 1990, 62 (01) : 23 - 27

[1] LOSS OF HETEROZYGOSITY ON CHROMOSOME-5 IN SPORADIC OVARIAN-CARCINOMA IS A LATE EVENT AND IS NOT ASSOCIATED WITH MUTATIONS IN APC AT 5Q21-22 [J]. HUMAN MUTATION, 1994, 3 (03) : 283 - 291

[2] ALLELOTYPE STUDY OF ESOPHAGEAL-CARCINOMA [J]. GENES CHROMOSOMES & CANCER, 1994, 10 (03) : 177 - 182

[3] ABNORMAL CHROMOSOMES INCLUDING SMALL METACENTRICS IN 14 OVARIAN CANCERS [J]. CANCER GENETICS AND CYTOGENETICS, 1987, 26 (02) : 355 - 361

[4] CHROMOSOME-ABERRATIONS IN METASTATIC OVARIAN-CANCER - RELATIONSHIP WITH ABNORMALITIES IN PRIMARY TUMORS [J]. INTERNATIONAL JOURNAL OF CANCER, 1990, 45 (01) : 50 - 54

[5] BERCHUCK A, 1992, HEMATOL ONCOL CLIN N, V6, P813

[6] OVEREXPRESSION OF P53 IS NOT A FEATURE OF BENIGN AND EARLY-STAGE BORDERLINE EPITHELIAL OVARIAN-TUMORS [J]. GYNECOLOGIC ONCOLOGY, 1994, 52 (02) : 232 - 236

[7] BEREK JS, 1993, ANN ONCOL, V4, P3

[8] THE SEARCH FOR THE FAMILIAL BREAST OVARIAN-CANCER GENE [J]. TRENDS IN GENETICS, 1993, 9 (01) : 22 - 26

[9] CONCLUSIONS AND RECOMMENDATIONS FROM THE HELENE-HARRIS-MEMORIAL-TRUST 4TH BIENNIAL INTERNATIONAL FORUM ON OVARIAN-CANCER 11-14 MAY 1993, TORONTO, CANADA [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1994, 4 (02) : 135 - 143

[10] DEMONSTRATION OF SOMATIC REARRANGEMENTS AND GENOMIC HETEROGENEITY IN HUMAN OVARIAN-CANCER BY DNA FINGERPRINTING [J]. BRITISH JOURNAL OF CANCER, 1990, 62 (01) : 23 - 27